Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany.
Pechmann A, Langer T, Schorling D, Stein S, Vogt S, Schara U, Kölbel H, Schwartz O, Hahn A, Giese K, Johannsen J, Denecke J, Weiß C, Theophil M, Kirschner J.
Pechmann A, et al. Among authors: langer t.
J Neuromuscul Dis. 2018;5(2):135-143. doi: 10.3233/JND-180315.
J Neuromuscul Dis. 2018.
PMID: 29689734
Free PMC article.